AAAAAA

   
Results: 1-22 |
Results: 22

Authors: THOR AD BERRY DA BUDMAN DR MUSS HB KUTE T HENDERSON IC BARCOS M CIRRINCIONE C EDGERTON S ALLRED C NORTON L LIU ET
Citation: Ad. Thor et al., ERBB-2, P53, AND EFFICACY OF ADJUVANT THERAPY IN LYMPH NODE-POSITIVE BREAST-CANCER, Journal of the National Cancer Institute, 90(18), 1998, pp. 1346-1360

Authors: WANG C THOR AD MOORE DH ZHAO Y KERSCHMANN R STERN R WATSON PH TURLEY EA
Citation: C. Wang et al., THE OVEREXPRESSION OF RHAMM, A HYALURONAN-BINDING PROTEIN THAT REGULATES RAS SIGNALING, CORRELATES WITH OVEREXPRESSION OF MITOGEN-ACTIVATEDPROTEIN-KINASE AND IS A SIGNIFICANT PARAMETER IN BREAST-CANCER PROGRESSION, Clinical cancer research, 4(3), 1998, pp. 567-576

Authors: WANG C THOR AD MOORE DH ZHAO Y KERSCHMANN R STERN R WATSON PH TURLEY EA
Citation: C. Wang et al., THE OVEREXPRESSION OF RHAMM, A HYALURONAN-BINDING PROTEIN THAT REGULATES RAS SIGNALING, CORRELATES WITH OVEREXPRESSION OF MITOGEN-ACTIVATEDPROTEIN-KINASE AND IS A SIGNIFICANT PARAMETER IN BREAST-CANCER PROGRESSION, Clinical cancer research, 4(3), 1998, pp. 567-576

Authors: CERDA SR TURK PW THOR AD WEITZMAN SA
Citation: Sr. Cerda et al., ALTERED EXPRESSION OF THE DNA-REPAIR PROTEIN, N-METHYLPURINE-DNA GLYCOSYLASE (MPG), IN BREAST-CANCER, FEBS letters, 431(1), 1998, pp. 12-18

Authors: KRAJEWSKI S THOR AD EDGERTON SM MOORE DH KRAJEWSKA M REED JC
Citation: S. Krajewski et al., ANALYSIS OF BAX AND BCL-2 EXPRESSION IN P53-IMMUNOPOSITIVE BREAST CANCERS, Clinical cancer research, 3(2), 1997, pp. 199-208

Authors: KUPRYJANCZYK J THOR AD BEAUCHAMP R POREMBA C SCULLY RE YANDELL DW
Citation: J. Kupryjanczyk et al., OVARIAN, PERITONEAL, AND ENDOMETRIAL SEROUS CARCINOMA - CLONAL ORIGINOF MULTIFOCAL DISEASE, Modern pathology, 9(3), 1996, pp. 166-173

Authors: DENG GR LU Y ZLOTNIKOV G THOR AD SMITH HS
Citation: Gr. Deng et al., LOSS OF HETEROZYGOSITY IN NORMAL TISSUE ADJACENT TO BREAST CARCINOMAS, Science, 274(5295), 1996, pp. 2057-2059

Authors: THOR AD KRAJEWSKI S EDGERTON SM MOORE D KRAJEWSKA M REED JC
Citation: Ad. Thor et al., IMMUNOHISTOCHEMICAL ANALYSIS OF BAX AND BCL-2 IN P53-IMMUOSUPPRESSIVEBREAST CANCERS, Laboratory investigation, 74(1), 1996, pp. 132-132

Authors: AXELSSON K LJUNG BME CHEW KL MAYALL BH MOORE DH SMITH HS THOR AD EDGERTON SM
Citation: K. Axelsson et al., TUMOR ANGIOGENESIS AS A PROGNOSTIC ASSAY FOR INVASIVE DUCTAL BREAST-CARCINOMA - RESPONSE, Journal of the National Cancer Institute, 87(23), 1995, pp. 1801-1802

Authors: AXELSSON K LJUNG BME MOORE DH THOR AD CHEW KL EDGERTON SM SMITH HS MAYALL BH
Citation: K. Axelsson et al., TUMOR ANGIOGENESIS AS A PROGNOSTIC ASSAY FOR INVASIVE DUCTAL BREAST-CARCINOMA, Journal of the National Cancer Institute, 87(13), 1995, pp. 997-1008

Authors: ZUKERBERG LR YANG WI GADD M THOR AD KOERNER FC SCHMIDT EV ARNOLD A
Citation: Lr. Zukerberg et al., CYCLIN D1 (PRAD1) PROTEIN EXPRESSION IN BREAST-CANCER - APPROXIMATELY1 3 OF INFILTRATING MAMMARY CARCINOMAS SHOW OVEREXPRESSION OF THE CYCLIN-D1 ONCOGENE/, Modern pathology, 8(5), 1995, pp. 560-567

Authors: KUPRYJANCZYK J BELL DA DIMEO D BEAUCHAMP R THOR AD YANDELL DW
Citation: J. Kupryjanczyk et al., P53 GENE ANALYSIS OF OVARIAN BORDERLINE TUMORS AND STAGE-I CARCINOMAS, Human pathology, 26(4), 1995, pp. 387-392

Authors: TAN PE BENZ CC DOLLBAUM C MOORE DH EDGERTON SM ZAVA DT THOR AD
Citation: Pe. Tan et al., PROGNOSTIC VALUE OF CATHEPSIN-D EXPRESSION IN BREAST-CANCER - IMMUNOHISTOCHEMICAL ASSESSMENT AND CORRELATION WITH RADIOMETRIC ASSAY, Annals of oncology, 5(4), 1994, pp. 329-336

Authors: BARNHILL RL CASTRESANA JS RUBIO MP MARTIN MT IDOATE M VAZQUEZ JJ THOR AD
Citation: Rl. Barnhill et al., P53 EXPRESSION IN CUTANEOUS MALIGNANT-MELANOMA - AN IMMUNOHISTOCHEMICAL STUDY OF 87 CASES OF PRIMARY, RECURRENT, AND METASTATIC MELANOMA, Modern pathology, 7(5), 1994, pp. 533-535

Authors: SHUSTER S THOR AD SMITH HS MOORE D STERN R
Citation: S. Shuster et al., DEPOSITION OF HYALURONIDASE IS AN INDICATOR FOR FAVORABLE OUTCOME IN BREAST-CANCER, Journal of cellular biochemistry, 1994, pp. 244-244

Authors: MUSS HB THOR AD BERRY DA
Citation: Hb. Muss et al., ADJUVANT THERAPY FOR BREAST-CANCER, The New England journal of medicine, 331(11), 1994, pp. 745-745

Authors: MUSS HB THOR AD BERRY DA KUTE T LIU ET KOERNER F CIRRINCIONE CT BUDMAN DR WOOD WC BARCOS M HENDERSON IC
Citation: Hb. Muss et al., C-ERBB-2 EXPRESSION AND RESPONSE TO ADJUVANT THERAPY IN WOMEN WITH NODE-POSITIVE EARLY BREAST-CANCER, The New England journal of medicine, 330(18), 1994, pp. 1260-1266

Authors: KUPRYJANCZYK J BELL DA BEAUCHAMP R YANDELL DW THOR AD
Citation: J. Kupryjanczyk et al., P53 ANALYSIS OF OVARIAN BORDERLINE TUMORS AND STAGE-I CARCINOMAS, Laboratory investigation, 70(1), 1994, pp. 10000091-10000091

Authors: CRYNS VL RUBIO MP THOR AD LOUIS DN ARNOLD A
Citation: Vl. Cryns et al., P53 ABNORMALITIES IN HUMAN PARATHYROID CARCINOMA, The Journal of clinical endocrinology and metabolism, 78(6), 1994, pp. 1320-1324

Authors: KUPRYJANCZYK J BELL DA YANDELL DW SCULLY RE THOR AD
Citation: J. Kupryjanczyk et al., P53 EXPRESSION IN OVARIAN BORDERLINE TUMORS AND STAGE-I CARCINOMAS, American journal of clinical pathology, 102(5), 1994, pp. 671-676

Authors: JACOBY AF FULLER AF THOR AD MUNTZ HG
Citation: Af. Jacoby et al., PRIMARY LEIOMYOSARCOMA OF THE FALLOPIAN-TUBE, Gynecologic oncology, 51(3), 1993, pp. 404-407

Authors: KUPRYJANCZYK J THOR AD BEAUCHAMP R MERRITT V EDGERTON SM BELL DA YANDELL DW
Citation: J. Kupryjanczyk et al., P53 GENE-MUTATIONS AND PROTEIN ACCUMULATION IN HUMAN OVARIAN-CANCER, Proceedings of the National Academy of Sciences of the United Statesof America, 90(11), 1993, pp. 4961-4965
Risultati: 1-22 |